<p><span style="font-size: small; background-color: #ffffff;"><strong>Hangzhou Peptide Biochem Co.,Ltd will attend CPHI Japan in 22-24 April, our booth No. is 2E-26 , welcome to our booth, we can offer the the custom service.</strong></span></p>
<p><span style="font-size: small;">1. Amidation and Acetylation</span></p>
<p><span style="font-size: small;">This is a good idea if the peptide is from an internal protein sequence. In the protein the ends of the peptide fragment would be amides (CONH2), and therefore amidation of the C‐terminus and acetylation of the N-terminus replicates this. These modifications also protect the peptide from enzymatic degradation.</span></p>
<p><span style="font-size: small;">2. Special Amino Acids</span></p>
<p><span style="font-size: small;">Unnatural amino acids result in peptidomimetics that may increase in‐vivo half life and potency. d‐Amino acids are often used instead of natural l‐amino acids to increase peptide stability against proteases. Replacing the N‐H of the amide backbone with N‐Methyl is useful for destabilising the formation of secondary structure and preventing peptide aggregation.</span></p>
<p><span style="font-size: small;">3. Phosphorylation</span></p>
<p><span style="font-size: small;">Peptides containing phospho‐serine, ‐threonine and/or ‐tyrosine are useful in replicating phospho‐protein</span></p>
<p><span style="font-size: small;">downstream effects.</span></p>
<p><span style="font-size: small;">4. Biotinylation</span></p>
<p><span style="font-size: small;">Biotin (244 Da) can be added to your peptide at various positions. Due to the very strong non‐covalent interaction</span></p>
<p><span style="font-size: small;">between biotin and avidin / streptavidin, it is useful to have this small molecule as a tag to immobilise the peptide, or to pull‐down the peptide from a mixture. Note that a spacer, such as a mini‐PEG or Ahx (aminohexanoic acid),</span></p>
<p><span style="font-size: small;">between biotin and the N‐terminus give a better performance in biotechnological applications generally.</span></p>
<p><span style="font-size: small;">5. PEGylation</span></p>
<p><span style="font-size: small;">PEG stands for polyethylene glycol, which is an uncharged, hydrophilic and non‐toxic polymer. A mini‐PEG (11‐</span></p>
<p><span style="font-size: small;">amino‐3,6,9‐trioxaundecanoic acid) is useful as a spacer between modifications such as a biotin or fluorescent tag, as it decreases interference in peptide folding and the peptide‐receptor binding interaction. Start your sequence with {mini‐PEG} if you want this spacer before an N‐terminal modification.</span></p>
<p><span style="font-size: small;">6. Fluorescent Labelling</span></p>
<p><span style="font-size: small;">Fluorescent labelling is the process of covalently attaching a fluorophore to your peptide, which can be done at a variety of positions and with a variety of fluorescent dyes. One of the most common dyes for labelling peptides is fluorescein and its derivatives, such as rhodamine. A common reagent used to label peptides with fluorescein is FITC,which stands for fluorescein isothiocyanate. Other fluorescent dyes used frequently to label peptides are coumarins(MCA and AMC), p‐nitroanilide and dansyl.</span></p>
<p><span style="font-size: small;">7. Cyclic Peptides</span></p>
<p><span style="font-size: small;">Cyclic peptides can be produced in several ways: (i) formation of a disulfide bond between two cysteine residues (up to three disulfide bonds can be made selectively); (ii) formation of an amide bond between the two ends of thepeptide (head to tail); or by (iii) formation of an amide bond involving at least one side chain residue in your peptide.</span></p>
<p><span style="font-size: small;">8. KLH and BSA</span></p>
<p><span style="font-size: small;">Since a peptide alone is unlikely to be immunogenic enough for antibody generation, it is often conjugated to a carrier protein, particularly keyhole limpet hemocyanin (KLH) or bovine serum albumin (BSA). KLH has the advantage in not interfering with western blots or ELISA assays. Note that KLH has limited solubility in water and may give a cloudy solution, but this does not affect immunogenicity.</span></p>
<p><span style="font-size: small;">9. MAPS</span></p>
<p><span style="font-size: small;">The multiple antigen peptide system (MAPS) uses a core peptide onto which your peptide is coupled. Either four or eight copies of the peptide (epitope) are displayed, depending on the core used. The core peptide is relatively small compared with carrier proteins (e.g. KLH). Also, the dense display of multiple copies of the antigenic epitope in a MAP produces a strong immunogenic response, without interference from a carrier protein.</span></p>
<p><span style="font-size: small;">10. Isotope Labelling</span></p>
<p><span style="font-size: small;">Peptides can be labelled with stable, nonradioactive isotopes, such as deuterium, carbon‐13 and nitrogen‐15. These isotopes are particularly useful for NMR spectroscopy. Please contact us with your peptide sequence and position of isotope label(s).</span></p>